Market & RegulationInvestment · $45M
OpenAI Backs Brain Implant Cancer Startup
WIRED AIhigh confidence
Why it matters
- →AI labs are actively investing in neurotech startups to secure access to high-value biological datasets.
- →Brain-computer interfaces are expanding beyond motor restoration into therapeutic oncology applications.
- →The involvement of major VCs validates the commercial potential of AI-driven neural signal analysis for cancer treatment.
Coherence Neuro has raised $45 million in seed funding led by OpenAI Startup Fund and Peter Thiel’s Founders Fund to develop an implantable device for detecting and treating brain cancer. The startup plans to use AI models to analyze neural signals associated with tumors and apply electrical stimulation to inhibit cancer growth, following successful short-term safety tests on three human patients. While OpenAI stated it will not access patient data, the investment underscores a broader industry trend of tech giants funding neurotechnology ventures to explore novel data sources for model training and medical applications.
Read originalThe story around this
TopicBrain Implants And Drug DiscoveryCooling
Earlier coverage that leads up to this article, and what followed. Lines connect each piece to the closest one after it, converging here.
More from WIRED AI
More in Market & Regulation
© TechCrunch AIMarket & Regulationother
Judge allows NAACP lawsuit over xAI pollution to proceed
xAI's attempt to dismiss the NAACP's Clean Air Act lawsuit failed after a federal judge ruled that its gas turbines are not exempt mobile sources and that plaintiffs have standing. This legal setback confirms that AI infrastructure operators cannot bypass environmental permitting by classifying heavy industrial equipment as temporary or mobile. The ruling forces xAI to face scrutiny over air quality impacts at its Colossus data center, setting a precedent for how large-scale compute facilities are regulated under existing environmental laws.
TechCrunch AI
© TechCrunch AI
